Trefoil factor 2 promotes cell proliferation in pancreatic β-cells through CXCR-4-mediated ERK1/2 phosphorylation

Kazuki Orime1, Jun Shirakawa, Yu Togashi

  • 1Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama-City University, 3-9 Fuku-ura, Kanazawa-ku, Yokohama 236-0004, Japan.

Endocrinology
|November 28, 2012
PubMed

Insights

Trefoil factor 2 (TFF2) promotes pancreatic beta-cell proliferation by activating ERK1/2 signaling via CX-chemokine receptor-4. This finding suggests TFF2 as a potential therapeutic target for increasing beta-cell mass in type 2 diabetes.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Molecular Medicine

Background:

  • Decreased pancreatic beta-cell mass is a key feature of type 2 diabetes.
  • Gastrointestinal incretin peptides are known to promote beta-cell proliferation.
  • Trefoil factor 2 (TFF2), a stomach-derived peptide, has roles in cell migration and proliferation, but its function in pancreatic beta-cells was unclear.

Purpose of the Study:

  • To investigate the mechanism by which TFF2 enhances pancreatic beta-cell proliferation.
  • To explore the potential of TFF2 as a therapeutic target for increasing beta-cell mass.

Main Methods:

  • TFF2 was overexpressed using adenovirus vectors or administered as a recombinant peptide in INS-1 cells, MIN6 cells, and mouse islets.
  • Cell proliferation was assessed by bromodeoxyuridine (BrdU) incorporation.
  • Gene expression of cyclins was analyzed using quantitative PCR.
  • ERK1/2 phosphorylation was measured by Western blot.
  • Specific inhibitors (U0126 for MAPK kinase, CX-chemokine receptor-4 antagonist) were used to elucidate signaling pathways.

Main Results:

  • TFF2 overexpression significantly increased BrdU incorporation in beta-cells, indicating enhanced proliferation, without affecting insulin secretion.
  • TFF2 upregulated the expression of key cell cycle regulators, including cyclins A2, D1, D2, D3, and E1.
  • TFF2 peptide treatment led to increased ERK1/2 phosphorylation and BrdU incorporation in MIN6 cells.
  • Inhibition of MAPK kinase or CX-chemokine receptor-4 abolished TFF2-induced beta-cell proliferation and ERK1/2 activation.

Conclusions:

  • TFF2 promotes pancreatic beta-cell proliferation through the CX-chemokine receptor-4-mediated activation of the ERK1/2 signaling pathway.
  • TFF2 represents a novel therapeutic target for strategies aimed at increasing beta-cell mass in type 2 diabetes.
  • Further research into TFF2's role could lead to new treatments for diabetes.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...